Biodesix Inc (BDSX)
1.585
-0.02
(-1.55%)
USD |
NASDAQ |
Jun 18, 16:00
1.585
0.00 (0.00%)
After-Hours: 18:08
Biodesix Enterprise Value: 208.71M for June 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 17, 2024 | 208.71M |
| June 14, 2024 | 207.56M |
| June 13, 2024 | 205.27M |
| June 12, 2024 | 200.68M |
| June 11, 2024 | 201.83M |
| June 10, 2024 | 183.48M |
| June 07, 2024 | 176.60M |
| June 06, 2024 | 173.16M |
| June 05, 2024 | 181.18M |
| June 04, 2024 | 175.45M |
| June 03, 2024 | 177.74M |
| May 31, 2024 | 188.07M |
| May 30, 2024 | 178.89M |
| May 29, 2024 | 181.18M |
| May 28, 2024 | 190.36M |
| May 24, 2024 | 190.36M |
| May 23, 2024 | 185.77M |
| May 22, 2024 | 198.39M |
| May 21, 2024 | 204.12M |
| May 20, 2024 | 204.12M |
| May 17, 2024 | 204.70M |
| May 16, 2024 | 202.97M |
| May 15, 2024 | 198.96M |
| May 14, 2024 | 195.52M |
| May 13, 2024 | 198.39M |
| Date | Value |
|---|---|
| May 10, 2024 | 205.27M |
| May 09, 2024 | 201.83M |
| May 08, 2024 | 201.83M |
| May 07, 2024 | 201.83M |
| May 06, 2024 | 198.39M |
| May 03, 2024 | 184.63M |
| May 02, 2024 | 174.30M |
| May 01, 2024 | 167.42M |
| April 30, 2024 | 166.28M |
| April 29, 2024 | 163.98M |
| April 26, 2024 | 165.70M |
| April 25, 2024 | 168.57M |
| April 24, 2024 | 168.57M |
| April 23, 2024 | 170.86M |
| April 22, 2024 | 172.01M |
| April 19, 2024 | 167.42M |
| April 18, 2024 | 167.42M |
| April 17, 2024 | 162.83M |
| April 16, 2024 | 167.42M |
| April 15, 2024 | 167.42M |
| April 12, 2024 | 165.13M |
| April 11, 2024 | 166.28M |
| April 10, 2024 | 165.13M |
| April 09, 2024 | 169.72M |
| April 08, 2024 | 161.06M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
32.38M
Minimum
Mar 30 2022
794.62M
Maximum
Jan 20 2021
193.07M
Average
144.90M
Median
Mar 31 2023
Enterprise Value Benchmarks
| Fonar Corp | 36.44M |
| XWELL Inc | -1.079M |
| ProPhase Labs Inc | 98.25M |
| Applied DNA Sciences Inc | -2.824M |
| Veracyte Inc | 1.425B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.61M |
| Revenue (Quarterly) | 14.82M |
| Total Expenses (Quarterly) | 25.77M |
| EPS Diluted (Quarterly) | -0.14 |
| Gross Profit Margin (Quarterly) | 78.57% |
| Profit Margin (Quarterly) | -91.87% |
| Earnings Yield | -34.70% |
| Normalized Earnings Yield | -33.58 |